Resources for Clinicians
Resources for Healthcare Professionals
March 2026 Town Hall – JM 101: Everything we Know about Juvenile Myositis in 2026
Watch this recorded Town Hall to learn more about juvenile myositis diagnosis and treatment. In this session, Dr. Stacey Tarvin shares insights into best practice
Early Promising Data in CAR-T for Myositis
We expected to hear promising news about the potential for CAR-T therapy to treat myositis at the Global Conference on Myositis (GCOM).
What we heard was more than promising—it was astounding.
What if I told you that there was a therapy that would “reset” the immune system—virtually eliminating the autoimmune response in myositis that causes inflammation, pain, muscle weakness, and other JM conditions of which we are all too familiar.
What We Know About Calcinosis & How to Treat It
Medically Reviewed by Angela Chun, MD on February 9, 2026 and Belina Yi, DO on February 25, 2026. Cure JM shares medical resources to support informed conversations
Home IVIG: A Family Perspective
Medically Reviewed by Dawn Wahezi, MD, MS on January 26, 2026. Cure JM shares family experiences to support informed conversations between families and their care teams. Intravenous
February 2026 Town Hall – Through Their Eyes: A Q&A Panel of Young Adults Living with JM
Our February Town Hall featured a conversation designed for parents, grandparents, and caregivers navigating life with Juvenile Myositis. A small panel of young adults in
Shared DNA Clues Point to Faster Treatments for Juvenile Myositis
In a study funded by the Cure JM Foundation and spearheaded by Dr. Younghun Han of the Baylor College of Medicine, scientists compared the DNA of more than three thousand people living with myositis to nearly twelve thousand healthy volunteers and found something striking. The major forms of myositis share much of the same genetic wiring.
RESET-Myositis Trial: CAR-T Cell Therapy (CABA-201)
Contact Info: A phase 1/ 2 clinical trial, investigating a treatment that uses your own T cells to treat myositis Who Can Participate: A study
January 2026 Cure JM Town Hall – Six Changes Families Will See in 2026
The January 2026 Cure JM Town Hall is about what’s changing for families this year—how care is evolving, what research opportunities are emerging, and how
Understanding Skin Symptoms in Juvenile Dermatomyositis: What Parents Can Learn from Recent Research
Based on a presentation by Grace A. Osborne, MD, PhD, Pediatric Dermatologist, University of Michigan at the January 2026 Cure JM Virtual Summit on JIIM
Descartes‑08: A New CAR‑T Trial for Juvenile Myositis and What Parents Should Know
Based on a presentation by Miloš Miljković, MD, PhD, Chief Medical Officer, Cartesian Therapeutics at the January 2026 Cure JM Virtual Summit on JIIM Research
Join Cure JM
Sign up and you will receive the quarterly Cure JM newsletter for clinicians and physicians.
